Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial

被引：42

作者：

Schneider, LS ^{[1
]}

Ismail, MS ^{[1
]}

Dagerman, K ^{[1
]}

Davis, S ^{[1
]}

Olin, J ^{[1
]}

McManus, D ^{[1
]}

Pfeiffer, E ^{[1
]}

Ryan, JM ^{[1
]}

Sultzer, DL ^{[1
]}

Tariot, PN ^{[1
]}

机构：

[1] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA

来源：

SCHIZOPHRENIA BULLETIN | 2003年 / 29卷 / 01期

关键词：

Alzheimer's disease; atypical antipsychotic; psychosis; dementia; effectiveness;

D O I：

10.1093/oxfordjournals.schbul.a006991

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This article describes the development of the protocol for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Alzheimer's disease trial, which was developed in collaboration with the National Institute of Mental Health to assess the effectiveness of atypical antipsychotics for psychosis and/or agitation occurring in outpatients with Alzheimer's disease. The article provides a detailed description of the methodology used in the trial as well as the clinical outcomes and effectiveness measures incorporated into it, discussing the most salient issues encountered in developing the design of the trial, as well as the unique features of the trial.

引用

页码：57 / 72

页数：16

共 57 条

[21]

Jeste DV, 1999, AM J GERIAT PSYCHIAT, V7, P70

[22] Psychosis of Alzheimer's disease and related dementias -: Diagnostic criteria for a distinct syndrome [J].

Jeste, DV ;

Finkel, SI .

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 8 (01) :29-34

[23]

JESTE DV, 1995, ARCH GEN PSYCHIAT, V52, P756

[24] Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients [J].

Jeste, DV ;

Lacro, JP ;

Bailey, A ;

Rockwell, E ;

Harris, MJ ;

Caligiuri, MP .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (06) :716-719

[25]

Kalbfleisch J.D., 1980, The statistical analysis of failure time data

[26]

KOCH GG, 2001, STAT METHODOLOGY PHA

[27] Relationship between CSF neurotransmitter metabolites and aggressive behavior in Alzheimer's disease [J].

Lopez, OL ;

Kaufer, D ;

Reiter, CT ;

Carra, J ;

DeKosky, ST ;

Palmer, AM .

EUROPEAN JOURNAL OF NEUROLOGY, 1996, 3 (02) :153-155

[28] The General Medical Health Rating: A bedside global rating of medical comorbidity in patients with dementia [J].

Lyketsos, CG ;

Galik, E ;

Steele, C ;

Steinberg, M ;

Rosenblatt, A ;

Warren, A ;

Sheppard, JM ;

Baker, A ;

Brandt, J .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (04) :487-491

[29]

MARTINEZ R, 2001, 1J A NN M AM ASS GER

[30]

MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939

← 1 2 3 4 5 6 →